FDA official details common reasons for missing ANDA review dates
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationGenericsHealth Authority meeting and communication strategyProduct developmentQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory strategyUnited States